Evidence map›Paper›PMID 42675545›Full record

ArticleChemMedChem2026

Oxadiazolone-Triazole Derivatives as a New Scaffold for Modulation of Angiotensin II-Induced Vascular Contraction.

Larissa F L Ferreira, Daiana G de A Vasconcelos, Ruth C A Santos, Jivaldo G Ferreira, Alice V Araújo, Janaína V Dos Anjos

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ChemMedChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Larissa F L FerreiraDepartment of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife, Brazil.ORCID https://orcid.org/0009-0006-5347-3858
Daiana G de A VasconcelosDepartment of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife, Brazil.
Ruth C A SantosVitória Academic Centre (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão, Pernambuco, Brazil.
Jivaldo G FerreiraVitória Academic Centre (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão, Pernambuco, Brazil.
Alice V AraújoVitória Academic Centre (CAV), Federal University of Pernambuco (UFPE), Vitória de Santo Antão, Pernambuco, Brazil.ORCID https://orcid.org/0000-0002-9728-8033
Janaína V Dos AnjosDepartment of Fundamental Chemistry, Federal University of Pernambuco (UFPE), Recife, Brazil.ORCID https://orcid.org/0000-0002-8842-8284

Funding

Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco APQ-1003.06/22Universidade Federal de Pernambuco Editais Propesqi 5/2024 and 6/2024
6 · The paper itself

Abstract

In this study, a series of novel angiotensin II type 1 receptor (AT

Indexed as

Angiotensin IIAngiotensin II Type 1 Receptor BlockersOxadiazolesTriazolesVasoconstrictionAnimalsAortaDose-Response Relationship, DrugMolecular Docking SimulationMolecular StructureRatsReceptor, Angiotensin, Type 1Structure-Activity RelationshipAngiotensin IIAngiotensin II Type 1 Receptor BlockersOxadiazolesoxadiazoloneReceptor, Angiotensin, Type 1Triazolesangiotensin receptor blockers (ARBs)click chemistryheterocycleshypertension

Identifiers

PMID42675545
PMCPMC13530322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.